JAK Inhibitors for Rheumatoid Arthritis: Historical Perspectives and Postmarketing Clinical Reports

With proper investigation, JAK inhibitors could revolutionize the treatment of many rheumatologic conditions.  

Join Rheumatology Network for free and access this whitepaper examining the potential for JAK inhibitors to improve patients' quality of life.

 

 

Related Videos
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Brian Lee, MD | Credit: AASLD
Transformations in Aortic Disease Management with Mehrdad Ghoreishi, MD | Image Credit: Baptist Health South Florida
Importance of Birch Triterpene Findings for Epidermolysis Bullosa, with Anna Bruckner, MD
Phase 3 Findings on Birch Triterpenes for Epidermolysis Bullosa, with Anna Bruckner, MD
© 2025 MJH Life Sciences

All rights reserved.